CF
Cantor Fitzgerald Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
151
HubSpot
HUBS
$25.7B
|
MV
Matthew Vanvliet
| $487.53 | $775 |
59%
upside
| Overweight |
3 Jun ‘25
3 months ago |
|
152
Freshworks
FRSH
$3.74B
|
MV
Matthew Vanvliet
| $12.84 | $20 |
56%
upside
| Overweight |
3 Jun ‘25
3 months ago |
|
153
Sprinklr
CXM
$1.91B
|
MV
Matthew Vanvliet
| $7.81 | $8 |
2%
upside
| Neutral |
3 Jun ‘25
3 months ago |
|
154
Tyler Technologies
TYL
$24.2B
|
MV
Matthew Vanvliet
| $559.96 | $600 |
7%
upside
| Neutral |
3 Jun ‘25
3 months ago |
|
155
BlackLine
BL
$3.32B
|
MV
Matthew Vanvliet
| $53.61 | $58 |
8%
upside
| Neutral |
3 Jun ‘25
3 months ago |
|
156
SPS Commerce
SPSC
$4.19B
|
MV
Matthew Vanvliet
| $110.60 | $170 |
54%
upside
| Overweight |
3 Jun ‘25
3 months ago |
|
157
Agilysys
AGYS
$3.1B
|
MV
Matthew Vanvliet
| $110.56 | $125 |
13%
upside
| Overweight |
3 Jun ‘25
3 months ago |
|
158
Q2 Holdings
QTWO
$4.92B
|
MV
Matthew Vanvliet
| $78.81 | $110 |
40%
upside
| Overweight |
3 Jun ‘25
3 months ago |
|
159
United Therapeutics
UTHR
$18.1B
|
OB
Olivia Brayer
| $400.52 | $405 |
1%
upside
| Overweight |
2 Jun ‘25
3 months ago |
|
160
Elastic
ESTC
$9.21B
|
TB
Thomas Blakey
| $86.71 | $92 |
6%
upside
| Neutral |
30 May ‘25
3 months ago |
|
|
CMPS
161
Compass Pathways
CMPS
$493M
|
JS
Josh Schimmer
| $5.14 | $12 |
133%
upside
| Overweight |
27 May ‘25
3 months ago |
|
162
Solid Biosciences
SLDB
$428M
|
KK
Kristen Kluska
| $5.50 | $16 |
191%
upside
| Overweight |
22 May ‘25
3 months ago |
|
163
Zoom
ZM
$25B
|
TB
Thomas Blakey
| $83.68 | $87 |
4%
upside
| Neutral |
22 May ‘25
3 months ago |
|
|
SERV
164
Serve Robotics
SERV
$616M
|
AS
Andres Sheppard
| $10 | $17 |
70%
upside
| Overweight |
22 May ‘25
3 months ago |
|
165
Seagate
STX
$40B
|
MP
Matthew Prisco
| $188.16 | $125 |
34%
downside
| Neutral |
19 May ‘25
3 months ago |
|
166
Analog Devices
ADI
$122B
|
CJM
C J Muse
| $247.07 | $250 |
1%
upside
| Neutral |
19 May ‘25
3 months ago |
|
167
Exagen
XGN
$213M
|
RO
Ross Osborn
| $9.67 | $7 |
28%
downside
| Overweight |
15 May ‘25
3 months ago |
|
168
Expedia Group
EXPE
$26.6B
|
DM
Deepak Mathivanan
| $214.95 | $170 |
21%
downside
| Neutral |
15 May ‘25
3 months ago |
|
169
Lucid Diagnostics
LUCD
$140M
|
RO
Ross Osborn
| $1.37 | $2 |
46%
upside
| Overweight |
15 May ‘25
3 months ago |
|
170
Fulcrum Therapeutics
FULC
$414M
|
KK
Kristen Kluska
| $7.66 | $10 |
31%
upside
| Overweight |
15 May ‘25
3 months ago |
|
171
Intuitive Machines
LUNR
$1B
|
AS
Andres Sheppard
| $8.49 | $16 |
88%
upside
| Overweight |
14 May ‘25
3 months ago |
|
172
Legend Biotech
LEGN
$6.66B
|
RB
Rick Bienkowski
| $36.08 | $55 |
52%
upside
| Overweight |
14 May ‘25
3 months ago |
|
173
Capricor Therapeutics
CAPR
$308M
|
KK
Kristen Kluska
| $6.74 | $30 |
345%
upside
| Overweight |
14 May ‘25
3 months ago |
|
174
Pharvaris
PHVS
$1.48B
|
TI
Timur Ivannikov
| $23.05 | $25 |
8%
upside
| Overweight |
14 May ‘25
3 months ago |
|
175
SoundThinking
SSTI
$157M
|
JR
Jonathan Ruykhaver
| $12.30 | $20 |
63%
upside
| Overweight |
14 May ‘25
3 months ago |
|